MerLion completes phase I of finafloxacin study

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 Nov, 2012

Singapore: Following successful first-in-man phase I and two phase IIa clinical studies with the oral formulation of fin...Read more

Changing the paradigm of drug development

Drug Discovery |  Opinion | By BioSpectrum Bureau  | 2 Comment | 08 Feb, 2013

Recent promising data on drug approvals in 2011 shows that there were 35 new molecular entities (NME) approved by the FD...Read more

Medivir, Daewoong end hepatitis drug development

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 09 Sep, 2013

Singapore: Sweden-based Medivir has discontinued the development of its hepatitis B compound MIV-210 based on a joint de...Read more

Eisai reveals phase III results of breast cancer drug Halaven

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jul, 2012

Singapore: Eisai revealed its preliminary results from a recently completed phase III study of Halaven versus capecitabi...Read more

Antidepressant can treat sickle cell disease

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 20 Feb, 2013

Singapore: A study by researchers at the University of Michigan Medical School, US, found that antidepressant drug trany...Read more

Pharmaxis to launch cystic fibrosis drug in Europe

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

Singapore: Australian pharmaceutical company Pharmaxis is all set to launch Bronchitol for cystic fibrosis (CF) patients...Read more

UK firm withdraws insulin marketing applications

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 1 Comment | 28 Nov, 2012

Singapore: UK's Marvel LifeScience, insulin marketing company, has withdrawn its application for centralized marketing a...Read more

Alchemia enrolls patients for cancer trial

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 01 Mar, 2013

Singapore: Alchemia has completed enrollment of patients in a pivotal phase III clinical trial evaluating its lead prod...Read more

Bayer, 5 cancer institutes set up oncology network

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jan, 2013

Sinapore: Bayer HealthCare in Singapore in collaboration with five research institutions have kaunched new Integrated Tr...Read more

Daiichi develops antibody to prevent fracture

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 16 Oct, 2012

Singapore: Daiichi Sankyo's 24-month randomized, double-blind, placebo-controlled multi-center phase III clinical trial ...Read more

Gilead to halt phase III study of leukemia drug

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 10 Oct, 2013

Singapore: Gilead Sciences plans to halt phase III study evaluating idelalisib in previously-treated chronic lymphocytic...Read more

Sihuan, NeuroVive to develop heart and brain products

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 21 Nov, 2012

Singapore: Sihuan Pharmaceutical entered into a collaboration agreement with NeuroVive Pharmaceutical to develop two in...Read more

Bioxyne to report COPD trial results in June

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 29 May, 2012

Singapore: Australian company Bioxyne closed its 320-patient study, which was designed to evaluate the efficacy and safe...Read more

MicuRx next gen antibiotic gets US patent

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 May, 2012

Singapore: MicuRx Pharmaceuticals, a privately-held biopharmaceutical company developing next-generation antibiotics, ha...Read more

MedImmune, UCSF enter 3-year R&D deal

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 18 Feb, 2014

Singapore: MedImmune, the global biologics R&D arm of AstraZeneca, has entered into a three-year collaboration with ...Read more

Biogen to commercialize MS therapies in Asia

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Feb, 2014

Singapore: Belgium based pharmaceutical company UCB and global pharmaceutical company, Biogen, have entered into an agre...Read more

BD launches Cell Analyzer to enhance drug discovery

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jul, 2013

Singapore: BD Biosciences, a global medical technology company, has launched BD LSRFortessa X-20 Cell Analyzer, to deliv...Read more

Viralytics melanoma study shows +ve results

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 25 Mar, 2013

Singapore: Assistant Professor (Dr) Robert H I Andtbacka presented a summary of his ongoing study with Viralytics' Cavat...Read more